prazosin has been researched along with Cardiovascular Diseases in 12 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prazosin is an orally active post-synaptic selective alpha 1-adrenoreceptor antagonist that has been widely used in treating hypertension and congestive heart failure (CHF)." | 10.15 | Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. ( Brogden, RN; Kellerman, D; Romankiewicz, JA; Stanaszek, WF, 1983) |
| "Prazosin is an orally active post-synaptic selective alpha 1-adrenoreceptor antagonist that has been widely used in treating hypertension and congestive heart failure (CHF)." | 6.15 | Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. ( Brogden, RN; Kellerman, D; Romankiewicz, JA; Stanaszek, WF, 1983) |
| " Twenty five unmedicated patients with primary hypertension were randomised to initial therapy with either the calcium antagonist, felodipine, or a diuretic and doses titrated to achieve similar levels of blood pressure (BP)." | 5.08 | Assessment of effects of two anti-hypertensive regimens on overall cardiovascular risk. ( Jennings, GL; Korner, P; Laufer, E; Reid, C; Sudhir, K, 1995) |
| "The combination of nifedipine and prazosin was more successful in preventing myocardial damage in 16 patients with hypertension than was nifedipine alone in two other patients with hypertension." | 3.68 | Management of the cardiovascular manifestations of poisoning by the Indian red scorpion (Mesobuthus tamulus). ( Bawaskar, HS; Bawaskar, PH, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Leary, MP | 1 |
| Stanaszek, WF | 1 |
| Kellerman, D | 1 |
| Brogden, RN | 1 |
| Romankiewicz, JA | 1 |
| Kather, H | 1 |
| Jennings, GL | 1 |
| Sudhir, K | 1 |
| Laufer, E | 1 |
| Korner, P | 1 |
| Reid, C | 1 |
| Bawaskar, HS | 5 |
| Bawaskar, PH | 5 |
| Warrell, DA | 1 |
| Souverein, PC | 1 |
| Herings, RM | 1 |
| De la Rosette, JJ | 1 |
| Man in 't Veld, AJ | 1 |
| Farmer, RD | 1 |
| Leufkens, HG | 1 |
| Rochette, G | 1 |
| Lecomte, J | 1 |
2 reviews available for prazosin and Cardiovascular Diseases
| Article | Year |
|---|---|
Treatment and pharmacologic management of BPH in the context of common comorbidities.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Co | 2006 |
Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Hea | 1983 |
3 trials available for prazosin and Cardiovascular Diseases
| Article | Year |
|---|---|
Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Hea | 1983 |
Assessment of effects of two anti-hypertensive regimens on overall cardiovascular risk.
Topics: Adolescent; Adult; Aged; Blood Pressure; Cardiovascular Diseases; Cholesterol; Diuretics; Drug Thera | 1995 |
Vasodilators: scorpion envenoming and the heart (an Indian experience).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Bradycardia; Cardiovascular Diseases; Child; Ch | 1994 |
8 other studies available for prazosin and Cardiovascular Diseases
| Article | Year |
|---|---|
[Hypertensive therapy with prazosin. Concomitant cardiovascular, metabolic and respiratory diseases. Proven facts and potential aspects].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Cardiovascular Diseases; Diabetes Complications; Humans; Hy | 1984 |
Prazosin: scorpion envenoming and the cardiovascular system.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Cardiovascular Diseases; Humans; Ind | 1997 |
Scorpion envenoming and the cardiovascular system.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Animals; Antihypertensive Agents; Cardiovascular Di | 1997 |
Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Adult; Aged; Bias; Cardiovascular Diseas | 2001 |
Management of the cardiovascular manifestations of poisoning by the Indian red scorpion (Mesobuthus tamulus).
Topics: Adult; Aged; Animals; Cardiovascular Diseases; Child; Child, Preschool; Drug Therapy, Combination; F | 1992 |
Treatment of cardiovascular manifestations of human scorpion envenoming: is serotherapy essential?
Topics: Animals; Antivenins; Cardiovascular Diseases; Humans; India; Nifedipine; Prazosin; Scorpion Stings; | 1991 |
Prazosin in management of cardiovascular manifestations of scorpion sting.
Topics: Adolescent; Adult; Animals; Cardiovascular Diseases; Child; Child, Preschool; Humans; Middle Aged; P | 1986 |
[Several cardiovascular manifestations induced by vibrational stimuli].
Topics: Adult; Autonomic Nervous System Diseases; Cardiovascular Diseases; Fingers; Humans; Hypertension; Me | 1985 |